Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

1 Stock to Buy Now That Could Make You Rich in 2023

Biopharmaceutical major Bristol-Myers Squibb Company (BMY) beat the consensus earnings and revenue estimates in the third quarter. Given its strong product pipeline, strategic acquisitions, discounted valuation, high profitability, strong financials, and attractive dividends, investors could buy the stock now. Read more….

StockNews.com

Britain and South Africa agree health partnership on second day of state visit

Britain and South Africa on Wednesday announced a new health and science partnership to mark the second day of President Cyril Ramaphosa's state visit to London, the first such official guest hosted by Britain's King Charles.

Reuters

UK and South Africa to strengthen health and climate partnership

The two nations signed an agreement during South African President Cyril Ramaphosa’s state visit to the UK.

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

COVID pill approval ups pandemic arsenal

The health ministry has granted emergency approval for a COVID-19 pill developed by Shionogi Co., opening the door for Japan's first domestically produced oral medicine for the virus to become available as soon as early December.

The Japan News/Yomiuri

Odisha launches Amlan to reduce anaemia

BHUBANESWAR: The Odisha government on Wednesday launched Anaemia Mukta Lakhya Abhiyan (Amlan), a multi-departmental campaign to reduce anaemia or haemoglobin deficiency in the state.

The Times of India

The growing menopause-at-work market

Little discussed and poorly understood, menopause — and the market for helping treat its accompanying symptoms — is gaining more attention when it comes to employer benefits.

Axios

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

New clinical trial will test whether infections need antibiotics

At present, medics may sometimes give out antibiotics unnecessarily because it is not clear whether an infection is caused by bacteria

Wales Online

Medical device companies upselling products to surgeons in operating theatres, insider claims

A former marketing manager for medical device companies says company reps would go into operating theatres ostensibly to give surgeons technical support, but with the prime aim of selling more products.

ABC News

$3.5M gene therapy for hemophilia gets FDA approval

U.S. health regulators have approved the first gene therapy for hemophilia, a blood-clotting disorder with few treatment options

The Independent UK

New booster shots cut risk of symptomatic COVID-19

WASHINGTON — The new bivalent COVID-19 booster shots are up to 56% more effective at preventing symptomatic COVID-19 infection than the two original COVID-19 vaccines in adults ages 18 and up, according to new data from the Centers for Disease Control and Prevention.

Tribune News Service

US renews push for COVID boosters as data show they protect

Americans who have gotten the updated COVID-19 boosters appear better protected against symptomatic infection than those who haven't — at least for now

The Independent UK

Britain says monkeypox shot offers strong 78% protection

A single dose of the monkeypox vaccine provides 78% protection against the virus, according to data from England released on Tuesday that health officials said was the strongest evidence yet of its effectiveness.

Reuters

Experts are concerned Thanksgiving gatherings could accelerate a 'tripledemic'

As the holiday approaches, infectious disease specialists are bracing for the possibility that big family get-togethers and travel will propel the spread of RSV, flu and COVID-19.

WEKU

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

RSV: Single jab approved for virus that can cause deadly pneumonia in babies

RSV can lead to severe lung issues in very young children including bronchiolitis and pneumonia

Axios

America shrugs off its twindemic

Americans are too COVID-fatigued to care.

Birmingham Post

Leeds' Tissue Regenix Group strikes agreement with German distributor

The Garforth-based business has signed a multi-year deal with the Hamburg firm

Radio France Internationale

EU drugs agency concerned about rising recreational use of 'laughing gas'

The European Union's drugs agency says that recreational use of laughing gas is an increasing worry in Europe, stressing that frequent use of this gas increases the risk of poisonings, burns and nervous system damage.

Get all your
news in one place.

100's of premium titles.
One news app.

The Canberra Times

ACT contact tracing app to be 'switched off'

Canberrans have not been required to check in since May.

Bangkok Post

Narcotics board 'has no sway' over cannabis orders: Wissanu

The Office of the Narcotics Control Board (ONCB) has no authority to alter or reverse any ministerial announcements signed by Public Health Minister Anutin Charnvirakul concerning the decriminalisation of cannabis, Deputy Prime Minister Wissanu Krea-ngam said on Monday.

Tribune News Service

More than 6,000 tech and biotech job cuts roil Bay Area economy

Tech and biotech companies have revealed plans recently for enough job cuts to erase more than 6,000 jobs in the Bay Area, cutbacks that could weigh on the region’s economy in the weeks and months to come.

Bangkok Post

Siriraj Hospital boosts aesthetic treatment safety

Derived from the bacterium Clostridium botulinum, Botulinum toxin type A (BoNT-A) is prescribed for uncontrollable blinking, chronic migraine, overactive bladder and other medical conditions, as well as aesthetic treatments.

StockNews.com

2 Biotech Stocks to Buy in November and 1 to Sell

The biotech industry strengthened over the pandemic by drug and vaccine development initiatives to combat COVID-19. Moreover, significant government investments should bode well for this industry. Therefore, quality biotech stocks Amgen (AMGN) and Gilead Sciences (GILD) could be ideal buys in November. However, fundamentally weak stock Ginkgo Bioworks (DNA) might…

Evening Standard

David Davis admits Brexit has not delivered ‘major’ economic benefits but blames Covid

The former Brexit Secretary blames Covid for failure of leaving the EU to deliver economic benefits to the UK

Irish Mirror

Laughing gas poisoning on the rise in Ireland

EU watchdog warning as one in four admit using nitrous oxide recreationally

1 … 96 97 98 99

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations